Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 14,301–14,329 of 14,329 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00155181	Molecular Mechanism of Nasopharyngeal Carcinoma	unknown	—	25	National Taiwan University HospitalOTHER	1	Sep 12, 2005	clinicaltrials
NCT00155272	Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma	unknown	Phase 1 / Phase 2	19	National Taiwan University HospitalOTHER	1	Sep 12, 2005	clinicaltrials